Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2253-2259
Published online before print July 27, 2006, doi: 10.1161/01.STR.0000236637.72124.3f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/9/2253    most recent
01.STR.0000236637.72124.3fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markus, H. S.
Right arrow Articles by Willeit, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markus, H. S.
Right arrow Articles by Willeit, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Carotid Artery Disease
*Smoking
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Glucose intolerance
Right arrow Carotid Stenosis
Right arrow Genetics of Stroke
Right arrow Risk Factors for Stroke
Right arrow Genetics of cardiovascular disease

(Stroke. 2006;37:2253.)
© 2006 American Heart Association, Inc.


Original Contributions

Genetic and Acquired Inflammatory Conditions Are Synergistically Associated With Early Carotid Atherosclerosis

Hugh S. Markus, DM, FRCP; Robyn Labrum, PhD; Steve Bevan, PhD; Markus Reindl, MD; Georg Egger, MD; Christian J. Wiedermann, MD; Qingbo Xu, PhD; Stefan Kiechl, MD Johann Willeit, MD

From the Centre for Clinical Neuroscience (H.S.M., R.L., S.B.) and John Parker Chair of Vascular Biology (Q.X.), Department of Cardiac and Vascular Sciences, St George’s University of London, UK; the Department of Neurology (M.R., S.K., J.W.), Innsbruck Medical University, Innsbruck, Austria; the Department of Internal Medicine (C.J.W.), Innsbruck Medical University, Innsbruck, Austria; and the Department of Internal Medicine (G.E.), Bruneck Hospital, Bruneck, Italy.

Correspondence to Professor Hugh Markus, Centre for Clinical Neuroscience, St George’s University of London, London, SW17 ORE. E-mail hmarkus{at}sgul.ac.uk

Background and Purpose— If chronic inflammation plays a causal role in atherogenesis, individuals with proinflammatory gene variants would be expected to develop more atherosclerosis. We recently found a synergistic association between 3 functional proinflammatory gene polymorphisms/haplotypes and smoking on carotid intima-media thickness (IMT). We replicated this finding in a second large population and extended the analysis by inclusion of other inflammatory conditions (chronic infection and obesity/abnormal glucose tolerance).

Methods— Common carotid and femoral artery IMT was determined in the Bruneck Study population (n=810). Proinflammatory variants were determined in 3 genes (IL-6 [–174C, –572G, –597A haplotype], IL-1–receptor antagonist [VNTR *2], and endotoxin receptor CD-14 [–159C]).

Results— There was a significant relationship between gene-variant score and carotid IMT: age- and sex-adjusted mean IMT in subjects with 0, 1, and ≥2 gene variants was 936, 987 and 1047 µm, respectively (P=0.001), and synergistic effects of gene-variant score and smoking on IMT measurements (P=0.040). Analogous findings were obtained for obesity/abnormal glucose tolerance and chronic infection. Interactive effects of gene-variant score and a risk factor score composed of the acquired inflammatory conditions were highly significant (P<0.001 each). Results were similar for femoral artery IMT.

Conclusions— These results provide support for a causal role of inflammation in carotid atherosclerosis, and emphasize the importance of gene-gene and gene-environment interactions in this pathogenic pathway. This may help to explain the substantial variability of disease expression in subjects with proinflammatory risk factors such as smoking, diabetes and chronic infection.


Key Words: atherosclerosis • carotid artery • genetics • inflammation • risk factors




This article has been cited by other articles:


Home page
StrokeHome page
S. Debette, S. Bevan, J.-F. Dartigues, M. Sitzer, M. Lorenz, P. Ducimetiere, P. Amouyel, and H. S. Markus
Fractalkine Receptor/Ligand Genetic Variants and Carotid Intima-Media Thickness
Stroke, June 1, 2009; 40(6): 2212 - 2214.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. K. Ohman, Y. Shen, C. I. Obimba, A. P. Wright, M. Warnock, D. A. Lawrence, and D. T. Eitzman
Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice
Circulation, February 12, 2008; 117(6): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Armstrong, S. Abilleira, M. Sitzer, H. S. Markus, and S. Bevan
Polymorphisms in MMP Family and TIMP Genes and Carotid Artery Intima-Media Thickness
Stroke, November 1, 2007; 38(11): 2895 - 2899.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Coll, S. Parra, C. Alonso-Villaverde, G. Aragones, M. Montero, J. Camps, J. Joven, and L. Masana
The Role of Immunity and Inflammation in the Progression of Atherosclerosis in Patients With HIV Infection
Stroke, September 1, 2007; 38(9): 2477 - 2484.
[Abstract] [Full Text] [PDF]